Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 320
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02811731 | Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B | ||
| NCT02480465 | Efficacy and Safety of Lobeglitazone Versus Sitagliptin | ||
| NCT05928637 | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150 | ||
| NCT01746680 | Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis | ||
| NCT05741437 | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378 | ||
| NCT02777723 | Study to Evaluate the Efficacy and Safety of CKD-350 | ||
| NCT04471441 | Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients. | ||
| NCT01819870 | Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg | ||
| NCT05549401 | Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 | ||
| NCT03062059 | The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence | ||
| NCT02685774 | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers | ||
| NCT02627027 | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers | ||
| NCT01297036 | Pharmacokinetic Comparisons of Two Donepezil Formulations | ||
| NCT02623868 | Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. | ||
| NCT03794492 | Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome | ||
| NCT05704621 | Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance | ||
| NCT04906785 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions | ||
| NCT02461004 | CKD-391 Pharmacokinetic Study | ||
| NCT05599152 | Comparison of Myocardial Infarction Patients Who Were Prescribed a Novel Antiplatelet Agent or Clopidogrel | ||
| NCT04867200 | A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers | ||
| NCT02916901 | Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers | ||
| NCT03739125 | Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes | ||
| NCT07304726 | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers | ||
| NCT06399068 | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions | ||
| NCT02565368 | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers | ||
| NCT01766518 | The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1) | ||
| NCT01356043 | CKD-828 Drug Interaction Study (S-amlodipine) | ||
| NCT03587558 | Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract | ||
| NCT05544214 | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects | ||
| NCT05238948 | CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects | ||
| NCT06044493 | MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients | ||
| NCT06281132 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults | ||
| NCT01991145 | Allogeneic UCB Therapy With EPO in Children With CP | ||
| NCT04258865 | A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 | ||
| NCT05897216 | Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029 | ||
| NCT03849287 | Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults | ||
| NCT07215637 | Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastatic Solid Tumors | ||
| NCT04354987 | Compare the Pharmacokinetics and Safety of CKD-391 | ||
| NCT03748212 | Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy Volunteers | ||
| NCT02586311 | CKD-330 Phase 3 Trial in Amlodipine Non-responder | ||
| NCT04488900 | Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects | ||
| NCT06643819 | Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A | ||
| NCT05952219 | Study to Evaluate the Safety and Pharmacokinetics of CKD-379 | ||
| NCT05566028 | The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes | ||
| NCT02159976 | Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea | ||
| NCT01630018 | Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial | ||
| NCT04867720 | Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients | ||
| NCT01983735 | Efficacy and Safety of TELMINUVO to Stage 2 Hypertension | ||
| NCT02066207 | CKD-337 Drug Interaction Study | ||
| NCT01106131 | Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin |
